Robert G Deeter

1.6k citations
31 papers · 1.2k indexed · 1 hit paper · h-index 14

Impact in

  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Neutropenia and Cancer Infections
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Robert G Deeter

31 papers receiving 1.2k citations

Hit Papers

A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer 2008 · 644 citations
6442008202620142020200400600

Peers

Robert G Deeter
Comparison fields: 5 of 87
  • Oncology 812
  • Hepatology 194
  • Pulmonary and Respiratory Medicine 325
  • Clinical Biochemistry 63
  • Pathology and Forensic Medicine 164
Replace Renaud Snanoudj with:
Renaud Snanoudj France
Jean‐Hugues Dalle France
Francesc Fernández‐Avilés Spain
Sebastian Dolff Germany
François Montestruc France
Maureen Reiner United States
Jean-Michel Rebibou France
Cristina Royo Spain
Wolfgang Arns Germany
Byung‐Sik Cho South Korea
Robert G Deeter relative to Renaud Snanoudj France Renaud Snanoudj's profile →
Citations per field
00.5×3.5×
Renaud Snanoudj · 1×
Citations per year

Countries citing papers authored by Robert G Deeter

Since Specialization
Citations

This map shows the geographic impact of Robert G Deeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G Deeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G Deeter more than expected).

Fields of papers citing papers by Robert G Deeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G Deeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G Deeter. The network helps show where Robert G Deeter may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert G Deeter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert G Deeter Line = papers co-authored together Robert G Deeter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
Hit paper breakdown →
2008644
2 201173
3 201370
4 200659
5
IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
200452
6
Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
200745
7 201343
8 201626
9
IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
200320
10 199120
11 199917
12 201215
13 200214
14
Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V.
199314
15 198713
16 199912
17 198912
18 199112
19 200811
20
Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
200510

About Robert G Deeter

Robert G Deeter is a scholar working on Applied Microbiology and Biotechnology, Oncology, Molecular Medicine, Pharmacology and Epidemiology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Neutropenia and Cancer Infections (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Herpesvirus Infections and Treatments (4 papers), Antibiotic Use and Resistance (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Blood disorders and treatments (3 papers). The work is most often cited by research in Oncology (812 citations), Hepatology (194 citations), Pulmonary and Respiratory Medicine (325 citations), Clinical Biochemistry (63 citations) and Pathology and Forensic Medicine (164 citations). Robert G Deeter has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Allen Lee Cohn, Tarek Chidiac, John L. Marshall, Rafael G. Amado, David R. Spigel, David McCollum, J. Randolph Hecht, Seta Shahin, Christopher Hagenstad and Edith P. Mitchell. Their work appears in journals such as Journal of Clinical Oncology, Blood, Antimicrobial Agents and Chemotherapy, Cornea and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026